Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Ms. Georgeann F. CoucharaSVP of HR | -281.00 | 45.50k | Sale to Issuer | 161.91 | 8.29k | -3.28% |
| 2026-05-01 | Mr. Alan G. SpoonIndependent Director | -1.36k | 139.59k | Derivative Exercise and Sale | 71.88 - 174.67 | 86.89k | - |
| 2026-05-01 | Mr. Alan G. SpoonIndependent Director | 1.94k | 139.45k | Derivative Exercise and Retained Stock | 71.88 | 86.89k | 2.28% |
| 2026-03-01 | Ms. Georgeann F. CoucharaSVP of HR | -113.00 | 23.80k | Sale to Issuer | 210.64 | 8.57k | -1.30% |
| 2026-03-01 | Ms. Julie Sawyer MontgomeryExec. VP of Diagnostics Platform | -1.08k | 227.49k | Sale to Issuer | 210.64 | 6.18k | -14.88% |
| 2026-03-01 | Mr. Christopher Paul RileyExec. VP of Biotechnology Group & CEO of Cytiva | -1.12k | 234.86k | Sale to Issuer | 210.64 | 20.40k | -5.18% |
| 2026-03-01 | Dr. Jose-Carlos Gutierrez-RamosSenior VP & Chief Science Officer | -284.00 | 59.82k | Sale to Issuer | 210.64 | 8.21k | -3.35% |
| 2026-03-01 | Mr. Matthew E. GuginoExec. VP & CFO | -231.00 | 48.66k | Sale to Issuer | 210.64 | 7.53k | -2.98% |
| 2026-03-01 | Mr. Gregory M. MilosevichExec. VP of Life Sciences Business | -118.00 | 24.86k | Sale to Issuer | 210.64 | 4.11k | -2.79% |
| 2026-03-01 | Mr. Christopher M. BoudaVP & CAO | -170.00 | 35.81k | Sale to Issuer | 210.64 | 6.91k | -2.40% |
| 2026-02-27 | Mr. Mitchell P. RalesCo-Founder & Director | -71.65k | 0.00 | Other Disposition | - | 33.76M | -0.21% |
| 2026-02-24 | Mr. Gregory M. MilosevichExec. VP of Life Sciences Business | -189.00 | 39.54k | Sale to Issuer | 209.19 | 4.91k | -3.71% |
| 2026-02-24 | Ms. Georgeann F. CoucharaSVP of HR | -101.00 | 21.13k | Sale to Issuer | 209.19 | 3.94k | -2.50% |
| 2026-02-24 | Mr. Christopher M. BoudaVP & CAO | -235.00 | 49.16k | Sale to Issuer | 209.19 | 6.52k | -3.48% |
| 2026-02-24 | Dr. Jose-Carlos Gutierrez-RamosSenior VP & Chief Science Officer | -344.00 | 71.96k | Sale to Issuer | 209.19 | 7.63k | -4.31% |
| 2026-02-24 | Mr. Christopher Paul RileyExec. VP of Biotechnology Group & CEO of Cytiva | -242.00 | 50.62k | Sale to Issuer | 209.19 | 15.34k | -1.55% |
| 2026-02-24 | Ms. Julie Sawyer MontgomeryExec. VP of Diagnostics Platform | -372.00 | 77.82k | Sale to Issuer | 209.19 | 5.10k | -6.80% |
| 2026-02-19 | Mr. Gregory M. MilosevichExec. VP of Life Sciences Business | -1.32k | 197.24k | Derivative Exercise and Sale | 58.59 - 208.01 | 5.10k | - |
| 2026-02-02 | Mr. Brian W. Ellisインサイダー | -1.25k | 280.17k | Sale to Issuer | 223.42 | 13.30k | -8.62% |
| 2026-02-02 | Dr. Jose-Carlos Gutierrez-RamosSenior VP & Chief Science Officer | -852.00 | 190.35k | Sale to Issuer | 223.42 | 7.98k | -9.65% |
| 2026-02-02 | Mr. Matthew R. McGrewExec. VP | -1.86k | 414.67k | Sale to Issuer | 223.42 | 28.44k | -6.13% |
| 2026-02-02 | Mr. Christopher Paul RileyExec. VP of Biotechnology Group & CEO of Cytiva | -640.00 | 142.99k | Sale to Issuer | 223.42 | 14.54k | -4.22% |
| 2026-02-02 | Mr. Rainer M. BlairPresident, CEO & Director | -7.75k | 1.73M | Sale to Issuer | 223.42 | 70.20k | -9.94% |
| 2025-11-25 | Mr. Mitchell P. RalesCo-Founder & Director | -40.63k | 9.36M | 売り | 230.27 - 231.19 | 33.83M | -0.12% |
| 2025-11-25 | Mr. Mitchell P. RalesCo-Founder & Director | -22.03k | 0.00 | Other Disposition | - | 33.87M | -0.06% |
| 2025-11-18 | Ms. Teri L. List-StollIndependent Director | -3.30k | 509.94k | Derivative Exercise and Sale | 71.88 - 226.50 | 23.00 | - |
| 2025-11-15 | Mr. Gregory M. MilosevichExec. VP of Life Sciences Business | -35.00 | 7.74k | Sale to Issuer | 221.21 | 4.42k | -0.79% |
| 2025-11-15 | Mr. R. Bradley GraySVP of Strategic Development | -1.40k | 310.14k | Sale to Issuer | 221.21 | 2.94k | -32.31% |
| 2025-11-15 | Ms. Julie Sawyer MontgomeryExec. VP of Diagnostics Platform | -265.00 | 58.62k | Sale to Issuer | 221.21 | 4.62k | -5.43% |
| 2025-11-11 | Mr. Matthew R. McGrewExec. VP | -16.17k | 2.45M | Derivative Exercise and Sale | 62.85 - 214.62 | 30.28k | - |
| 2025-11-12 | Mr. Brian W. Ellisインサイダー | -21.78k | 3.50M | Derivative Exercise and Sale | 58.59 - 219.23 | 14.55k | - |
| 2025-11-12 | Mr. Mitchell P. RalesCo-Founder & Director | -437.00k | 95.57M | 売り | 217.64 - 220.15 | 33.90M | -1.27% |
| 2025-11-10 | Ms. Georgeann F. CoucharaSVP of HR | -4.18k | 510.32k | Derivative Exercise and Sale | 88.24 - 210.44 | 2.63k | - |
| 2025-11-10 | Ms. Georgeann F. CoucharaSVP of HR | -998.00 | 209.89k | 売り | 210.31 | 2.63k | -27.55% |
| 2025-10-31 | Mr. Mitchell P. RalesCo-Founder & Director | -600.00k | 129.64M | 売り | 215.67 - 217.17 | 34.33M | -1.72% |
| 2025-08-22 | Ms. Teri L. List-StollIndependent Director | -2.78k | 586.32k | 売り | 211.06 | 12.00 | -99.57% |
| 2025-07-15 | Dr. Elias Adam ZerhouniIndependent Director | 2.72k | 161.35k | Derivative Exercise and Retained Stock | 59.34 | 15.61k | 21.09% |
| 2025-07-15 | Dr. Elias Adam ZerhouniIndependent Director | -1.21k | 161.43k | Derivative Exercise and Sale | 59.34 - 192.86 | 15.61k | - |
| 2025-07-15 | Mr. John T. Schwietersインサイダー | 2.72k | 161.35k | Derivative Exercise and Retained Stock | 59.34 | 40.96k | 7.11% |
| 2025-07-15 | Mr. John T. Schwietersインサイダー | -1.21k | 161.43k | Derivative Exercise and Sale | 59.34 - 192.86 | 40.96k | - |
| 2025-07-15 | Mr. Christopher M. BoudaVP & CAO | -61.00 | 11.76k | Sale to Issuer | 192.86 | 6.27k | -0.96% |
| 2025-07-02 | Ms. Teri L. List-StollIndependent Director | 2.78k | 164.85k | Derivative Exercise and Retained Stock | 59.34 | 2.78k | - |
| 2025-07-02 | Ms. Teri L. List-StollIndependent Director | -1.15k | 164.90k | Derivative Exercise and Sale | 59.34 - 202.73 | 2.78k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
